Sim&Cure

Montpellier, France · Founded 2013 · Privately Held (backing)

Developer of a patient-specific device designed to secure the treatment of a cerebral aneurysm. Sim&Cure is based in Montpellier, France and was founded in 2013. Its last reported valuation was $48.7 million in Nov 2025. It has raised $21.1 million.

Last reported valuation
$48.7M
Oct 2026
Priced at
—
Total raised
$21.1M
Last round
—
No prints on record

No secondary trades in Sim&Cure shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sim&Cure with a free account
  • ·The complete investor list: 13 names
  • ·Watch Sim&Cure: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Sim&Cure prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Sim&Cure stock.